Pregnancy and Birth

The comprehensive review found no evidence linking HPV vaccination to neurological conditions or adverse pregnancy outcomes across 20 years of data.

While neonatal outcomes remained stable, the use of piperacillin-tazobactam for chorioamnionitis was linked to a significantly longer maternal readmission length of stay.

Following the presentation of real-world data at HRS 2026, Ridhima Kapoor, MD, details the importance of using continuous 14-day ECG patches to capture arrhythmia burden in pregnant populations.

The review of over 120 studies published since 2024 found no credible evidence linking HPV vaccination to serious adverse pregnancy outcomes or other long-term health risks.

Per CNN, Alito’s order is in effect until May 11, with responses to the case requested by Thursday, May 7.

At ACOG, Julie Anderson presented data demonstrating that virtual birth planning is associated with a nearly 4-fold increase in shared decision-making for high-risk patients.

During clinical validation done by the company, Unity Confirm demonstrated 100% concordance with known fetal outcomes and invasive diagnostic results in 16 samples.

Molly Dickinson, DO, describes a rare case where a 22-week uterine rupture was repaired allowing the pregnancy to continue to a successful 32-week delivery.

Maternal dairy intake was consistently associated with lower concentrations of numerous human milk lipid species.

Nicole Sparks, MD, discusses anesthesia approaches, evolving c-section trends, and the growing emphasis on opioid-sparing pain management and postpartum recovery.

A matched cohort study of nearly 14,000 singleton pregnancies found no association between same-day influenza and pertussis vaccination during pregnancy and increased rates of preterm birth, small for gestational age, low birth weight, or any assessed secondary adverse outcome compared with pertussis vaccination alone.

Data presented at HRS 2026 indicates that nearly 60% of arrhythmias in pregnant patients are first detected after the initial 48 hours of cardiac monitoring.

Rachel Sood, NP-C, CDCES, highlights how the FDA clearance of Control-IQ+ provides the clinical proof needed to expand the use of AID systems in T1D pregnancies.

The expanded label to include use during pregnancy complicated by type 1 diabetes mellitus is based on data from the CIRCUIT trial.

"Results remained similar in subgroup analyses of early- and late-onset, and preterm and term preeclampsia," according to findings.

Effective January 1, 2027, the Current Procedural Terminology codes will replace the global maternity payment model to bill for antepartum, labor, delivery, and postpartum phases.

The incidence of SUI at 6 weeks post partum was 8.7% for the PEFLOW group compared to 13.9% for those receiving usual care (P = .03).

Institutions can meaningfully reduce racial disparities in urine toxicology testing at delivery by eliminating universal testing and adopting any standardized criteria-based screening protocol—provided the criteria are grounded in clinical evidence rather than demographic variables that function as proxies for race.

Conditions like chorioamnionitis change the pH of the surgical environment, which can prevent local anesthetics from working optimally, according to Beth Ann Clayton.

New research indicates significant disparities in immediate STI antibiotic administration in emergency departments based on pregnancy status.

Scott Sullivan, MD, describes a new strategy of training ER staff in hospitals without OB services to manage "drop-in" obstetric emergencies through simulation and remote support.

According to Amy Sarma, MD, moving beyond episodic office visits to multimodality care strategies is essential for reducing adverse cardiovascular outcomes in high-risk patients.

Scott Sullivan, MD, highlights that a third of Virginia is a maternity desert, creating even more severe gaps for patients requiring maternal-fetal medicine.

Routine ultrasound screening at 35 to 37 weeks demonstrates limited accuracy for large-for-gestational age according to new data published in AJOG.

"Given the upper limits of the CI, a relatively higher risk of more than 12% for autism is unlikely to be associated with acetaminophen exposure," the study authors noted.